Back to all studies
CompletedNCT02146547

European Long-acting Antipsychotics in Schizophrenia study

This study is completed. It focuses on schizophrenia and currently lists study information in Austria, Belgium, Bulgaria, Czech Republic, Denmark, Germany, Greece, Hungary, Israel, Italy, the Netherlands, Norway, Poland, Romania, Spain, and the United Kingdom.

SchizophreniaDrugOver 18 Years

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Then choose your country and confirm availability with each study site.

In plain English

Key information made simple

What is this study testing?

This study is testing whether Aripiprazole may be useful for adults experiencing schizophrenia.

What would participation involve?

Participants may receive Aripiprazole, attend study visits with the research team. The registry lists locations in Austria, in Belgium, and in Bulgaria.

Who is it mainly for?

This study appears to be mainly for adults with schizophrenia.

What should you check before joining?

Ask about the dose, safety monitoring, and possible side effects, whether there is a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.

Your next step

Check the study details

Check the official source, then confirm these points with the research team.

View official study record (opens in a new tab)
  • Recruitment and eligibility

    Is a site open, and who can take part?

  • Visits and time

    Where are visits, can any be remote, and how much time is needed?

  • Costs and support

    What costs, reimbursement or compensation apply?

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateStarted: February 2015
Recruitment status
Completed
Enrollment listed in the registry
536
Sponsor
UMC Utrecht
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United Kingdom, Belgium, Austria, ...
Age range
Over 18 Years
Official registry ID
NCT02146547
Official title
European Long-acting Antipsychotics in Schizophrenia Trial

Ask HopeStage to help me review this study

This record does not confirm open recruitment. We can help you understand it and explore other studies.

Loading the security check...
Study ID: NCT02146547. We help you review the study, but cannot decide medical eligibility.

Check recruitment and locations

Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.

View official study record (opens in a new tab)

The overall study status can differ from each site's status. Open a country to see its locations and their registry status.

Austria · 2 sites
  • Department of Biological Psychiatry, Innsbruck University Clinics
    Innsbruck, Anichstrasse 35
    Site status: Not listed — confirm with the team
  • Psychosoziale Dienste
    Vienna, Modecenterstraße
    Site status: Not listed — confirm with the team
Belgium · 2 sites
  • ZNA, department of Psychiatry, locatie Stuivenberg
    Antwerp, Lange Beeldekensstraat 267
    Site status: Not listed — confirm with the team
  • Psychiatrisch Ziekenhuis Duffel
    Antwerp, Stationsstraat 22C
    Site status: Not listed — confirm with the team
Bulgaria · 1 site
  • University Hospital of Neurology and Psychiatry 'St. Naum' 1
    Sofia, Louben Roussev Str.
    Site status: Not listed — confirm with the team
Czechia · 3 sites
  • Psychiatrická klinika LF UK
    Hradec Králové, Fakultní Nemocnice
    Site status: Not listed — confirm with the team
  • Dr. Ustohal
    Brno
    Site status: Not listed — confirm with the team
  • Dr. Mohr
    Prague
    Site status: Not listed — confirm with the team
Denmark · 1 site
  • Center for Neuropsychiatric Research
    Glostrup Municipality, Ndr. Ringvej
    Site status: Not listed — confirm with the team
Germany · 4 sites
  • Klinik und Poliklinik für Psychiatrie und Psychotherapie der Heinrich-Heine-Universität
    Düsseldorf, Bergische Landstraße 2
    Site status: Not listed — confirm with the team
  • Technische Universität München (TUM
    München, Ismaningerstrasse 22
    Site status: Not listed — confirm with the team
  • Klinik für Psychiatrie, Psychotherapie und Psychosomatik der Martin-Luther-Universität
    Halle, Julius-Kühn-Straße 7
    Site status: Not listed — confirm with the team
  • Department of Psychiatry and Psychotherapy
    München, Nussbaumstrasse 7
    Site status: Not listed — confirm with the team
Greece · 1 site
  • National and Kapodistrian University of Athens Medical School, Eginition Hospital
    Athens
    Site status: Not listed — confirm with the team
Hungary · 2 sites
  • Dr. Csekey
    Balassagyarmat
    Site status: Not listed — confirm with the team
  • Department of Psychiatry and Psychotherapy, Semmelweis University
    Budapest
    Site status: Not listed — confirm with the team
Israel · 6 sites
  • Abravanel Mental Health Center
    Bat Yam
    Site status: Not listed — confirm with the team
  • Be'er-Ness Mental Health Center
    Be’er Ya‘aqov
    Site status: Not listed — confirm with the team
  • The Jerusalem Mental Health Center
    Jerusalem
    Site status: Not listed — confirm with the team
  • Lev-Hasharon Medical Center for Mental Health
    Pardesiyya
    Site status: Not listed — confirm with the team
  • Geha Medical Health Center
    Petah Tikva
    Site status: Not listed — confirm with the team
  • The Chaim Sheba Medical Center
    Tel Litwinsky
    Site status: Not listed — confirm with the team
Italy · 3 sites
  • Department of Psychiatry, University of Naples SUN
    Naples, Largo Madonna Delle Grazie 1
    Site status: Not listed — confirm with the team
  • Università degli Studi di Torino. Dipartimento di Neuroscienze
    Turin, Sezione Di Psichiatriavia Cherasco, 11
    Site status: Not listed — confirm with the team
  • Servizio Psichiatrico Universitario di Diagnosi e Cura. Presidio Ospedaliero "San Salvatore" Università degli Studi dell'Aquila.
    L’Aquila
    Site status: Not listed — confirm with the team
Netherlands · 1 site
  • University Medical Center
    Utrecht
    Site status: Not listed — confirm with the team
Norway · 3 sites
  • Helse Bergen HF Haukeland University Hospital, Division of Psychiatry
    Bergen
    Site status: Not listed — confirm with the team
  • Stavanger University Hospital
    Stavanger
    Site status: Not listed — confirm with the team
  • St Olavs Hospital avd Østmarka / INM NTNU
    Trondheim
    Site status: Not listed — confirm with the team
Poland · 2 sites
  • Instytut psychiatrii i neurologii
    Warsaw, Sobieskiego 9
    Site status: Not listed — confirm with the team
  • II Klinika Psychiatrii Uniwersytet Medyczny w Lublinie
    Lublin, Ul. Głuska 1
    Site status: Not listed — confirm with the team
Romania · 6 sites
  • Spitalul Clinic Judetean de Urgenta Arad - Clinica de Psihiatrie
    Arad
    Site status: Not listed — confirm with the team
  • Spitalul Clinic de Psihiatrie "Prof. Dr. Alexandru Obregia"
    Bucharest
    Site status: Not listed — confirm with the team
  • Spitalul Clinic de Psihiatrie "Prof. Dr. Alexandru Obregia
    Bucharest
    Site status: Not listed — confirm with the team
  • Spitalul de Psihiatrie si pentru Masuri de Siguranta, Sapoca, Buzau
    Buzău
    Site status: Not listed — confirm with the team
  • Spitalul Clinic de Neuropsihiatrie Craiova
    Craiova
    Site status: Not listed — confirm with the team
  • Sitalul Clinic Judetean Mures
    Targu Mureş
    Site status: Not listed — confirm with the team
Spain · 4 sites
  • Hospital Clínic de Barcelona. Unidad de Esquizofrenia
    Barcelona, C/Villarroel, 170. Escalera12, Planta 0
    Site status: Not listed — confirm with the team
  • Hospital Universitario Marqués de Valdecilla, Servicio de Psiquiatría
    Santander, Cantabria
    Site status: Not listed — confirm with the team
  • Facultad de Medicina Center
    Oviedo, Julián Clavería S/n
    Site status: Not listed — confirm with the team
  • Child and Adolescent Psychiatry Department. Hospital General Universitario Gregorio Marañón. Servicio Madrileño de Salud
    Madrid
    Site status: Not listed — confirm with the team
United Kingdom · 8 sites
  • West London Mental Health Trust. East Recovery Team
    London, Avenue House 43-47 Avenue Road
    Site status: Not listed — confirm with the team
  • Greater Manchester West Mental Health NHS Foundation Trust
    Manchester, Crowell House, Cromwell Road
    Site status: Not listed — confirm with the team
  • Edmund Ward, St Martins Hospital Littlebourne Road Canterbury
    Kent
    Site status: Not listed — confirm with the team
  • Imperial College, Centre for Mental Health, Faculty of Medicine,
    London
    Site status: Not listed — confirm with the team
  • Tees, Ask and Wearvalleys
    Middlesbrough
    Site status: Not listed — confirm with the team
  • Northumberland
    Newcastle
    Site status: Not listed — confirm with the team
  • Oxford Health NHS Foundation Trust
    Oxford
    Site status: Not listed — confirm with the team
  • Surrey and Borders Partnership NHS Foundation Trust
    Surrey
    Site status: Not listed — confirm with the team
In practice

For you

Participation may contribute to research. Personal benefit is not guaranteed.

Ask the research team to explain the activities, time commitment, and follow-up involved.

Study sites are listed. Confirm the relevant site and any travel before making plans.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

This study is exploring medication or study treatment for people with schizophrenia. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.

Does this study involve a medication?

This appears to be a medication / drug study involving Aripiprazole, Aripiprazole depot, Paliperidone, Paliperidone palmitate. Phase 4 studies usually happen after treatment approval, to monitor real-world use.

Who might this study be for?

This study may concern people with schizophrenia; age range: Over 18 Years. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.

What would I likely need to do?

You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.

What side effects, interactions, or treatment changes should I check?

If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.

Will I need to travel or attend in-person visits?

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

Who is behind this study?

This study is sponsored by UMC Utrecht, which appears to be unknown or unclear. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me